Article: Nicotinamide Riboside Supplementation Increases NAD+ Levels in Humans: Clinical Findings

Jul 5, 2019 Clinical Pharmacokinetic/Safety

Nicotinamide Riboside Supplementation Increases NAD+ Levels in Humans: Clinical Findings

Objectives

To evaluate the safety and efficiacy of NR supplementation in overweight, but otherwise healthy men and women.

Journal

Scientific Reports

Key Outcomes

NR supplementation significantly and dose-dependently increased whole blood NAD+ levels by 22%, 51%, and 142%, respectively, within two weeks. These levels were maintained throughout the remainder of the study.

Duration

8 weeks

Dose

100 mg
300 mg
1000 mg

Study Design

Randomized, double-blind, placebo-controlled, parallel assignment study in 140 overweight, but otherwise healthy men and women

See Published Study

Autism Spectrum Disorder

Nicotinamide Riboside Reduces Liver Fibrosis: Preclinical Findings

Synopsis Liver fibrosis is part of the non-alcoholic fatty liver disease (NAFLD) spectrum, which currently has no approved pharmacological treatment. Researchers tested whether nicotinamide ribosi...

Healthy Aging & Longevity

NAMPT Deficiency in Mouse Liver Cells Shows Minimal Impact on NAD+ and Mitochondrial Health: Preclinical Findings

Synopsis Supplementation with NAD+ precursors such as nicotinamide riboside (NR) has been shown to improve mitochondrial function and prevent liver fat accumulation in high-fat diet (HFD)-fed rode...